Gene expression in inherited breast cancer.

[1]  Cancer Epidemiol Biomarkers Prev , 2004 .

[2]  Dustin Boswell,et al.  Introduction to Support Vector Machines , 2002 .

[3]  Carsten O. Peterson,et al.  Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.

[4]  Curtis C. Harris,et al.  Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis , 2001, Nature Genetics.

[5]  G. Li,et al.  Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1. , 2001, Biochemical and biophysical research communications.

[6]  John Quackenbush,et al.  Computational genetics: Computational analysis of microarray data , 2001, Nature Reviews Genetics.

[7]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[8]  J. Mulvihill,et al.  Single nucleotide polymorphism in prohibitin 3′untranslated region and breast-cancer susceptibility , 2001, The Lancet.

[9]  T. Ohta,et al.  The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation* , 2001, The Journal of Biological Chemistry.

[10]  H. Dietz,et al.  A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition , 2001, Nature Biotechnology.

[11]  D. Sgroi,et al.  BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function , 2001, Cell.

[12]  O. Kallioniemi,et al.  Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.

[13]  U. Alon,et al.  Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. , 2001, Cancer research.

[14]  J. Manley,et al.  The BARD1-CstF-50 Interaction Links mRNA 3′ End Formation to DNA Damage and Tumor Suppression , 2001, Cell.

[15]  E. Dougherty,et al.  Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.

[16]  P. Møller,et al.  Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. , 2001, Human molecular genetics.

[17]  S C West,et al.  Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. , 2001, Molecular cell.

[18]  G. Giles,et al.  After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. , 2001, American journal of human genetics.

[19]  D. Easton,et al.  Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. , 2001, American journal of human genetics.

[20]  S. Ganesan,et al.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. , 2001, Molecular cell.

[21]  R. Shiekhattar,et al.  A Human BRCA2 Complex Containing a Structural DNA Binding Component Influences Cell Cycle Progression , 2001, Cell.

[22]  M. Erdos,et al.  Role of direct interaction in BRCA1 inhibition of estrogen receptor activity , 2001, Oncogene.

[23]  A. Brazma,et al.  Gene expression data analysis , 2000, FEBS letters.

[24]  G. Coetzee,et al.  Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. , 2001, Cancer research.

[25]  T. Miyake,et al.  Characterization of a Novel Trans-Activation Domain of BRCA1 That Functions in Concert with the BRCA1 C-terminal (BRCT) Domain* , 2000, The Journal of Biological Chemistry.

[26]  R. Scully,et al.  DNA polymerase stalling, sister chromatid recombination and the BRCA genes , 2000, Oncogene.

[27]  Wen-Hwa Lee,et al.  Lessons learned from BRCA1 and BRCA2 , 2000, Oncogene.

[28]  R. Fishel,et al.  BRCA1 and cell signaling , 2000, Oncogene.

[29]  D. Livingston,et al.  In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.

[30]  Y. Houvras,et al.  BRCA1 Physically and Functionally Interacts with ATF1* , 2000, The Journal of Biological Chemistry.

[31]  F. Couch,et al.  Induction of the BRCA2 Promoter by Nuclear Factor-κB* , 2000, The Journal of Biological Chemistry.

[32]  R A Irvine,et al.  Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. , 2000, Cancer research.

[33]  A. Monteiro,et al.  BRCA1: exploring the links to transcription. , 2000, Trends in biochemical sciences.

[34]  P. L. Chen,et al.  Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. , 2000, Molecular cell.

[35]  B. Weber,et al.  Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. , 2000, American journal of human genetics.

[36]  J M Trent,et al.  MYB oncogene amplification in hereditary BRCA1 breast cancer. , 2000, Cancer research.

[37]  Nello Cristianini,et al.  Support vector machine classification and validation of cancer tissue samples using microarray expression data , 2000, Bioinform..

[38]  S. Seal,et al.  Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22 , 2000, Oncogene.

[39]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[40]  Y. Chen,et al.  Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. , 2000, Journal of the National Cancer Institute.

[41]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[42]  J. Minna,et al.  Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome , 2000, Genes, chromosomes & cancer.

[43]  C. Deng,et al.  Roles of BRCA1 and its interacting proteins , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[44]  Alexander Kinev,et al.  BRCA1 Is Associated with a Human SWI/SNF-Related Complex Linking Chromatin Remodeling to Breast Cancer , 2000, Cell.

[45]  Y. Shiloh,et al.  Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response , 2000, Nature.

[46]  W. Willett,et al.  Polymorphic repeat in AIB1 does not alter breast cancer risk , 2000, Breast Cancer Research.

[47]  R. Baer,et al.  Nuclear Localization and Cell Cycle-specific Expression of CtIP, a Protein That Associates with the BRCA1 Tumor Suppressor* , 2000, The Journal of Biological Chemistry.

[48]  J. Herman,et al.  Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. , 2000, Journal of the National Cancer Institute.

[49]  T. Katagiri,et al.  Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1. , 2000, Cancer research.

[50]  Jong-Soo Lee,et al.  hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response , 2000, Nature.

[51]  Carlos Caldas,et al.  Mutations truncating the EP300 acetylase in human cancers , 2000, Nature Genetics.

[52]  M. Stratton,et al.  The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[53]  C. Deng,et al.  Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation , 2000, Oncogene.

[54]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[55]  M. King,et al.  Insights into the functions of BRCA1 and BRCA2. , 2000, Trends in genetics : TIG.

[56]  Fritz F. Parl,et al.  Estrogens, Estrogen Receptor, and Breast Cancer , 2000 .

[57]  M. Saraste,et al.  FEBS Lett , 2000 .

[58]  Nir Friedman,et al.  Tissue classification with gene expression profiles. , 2000 .

[59]  K. Isselbacher,et al.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.

[60]  T. Stankovic,et al.  The DNA Double-Strand Break Repair Gene hMRE11 Is Mutated in Individuals with an Ataxia-Telangiectasia-like Disorder , 1999, Cell.

[61]  S. Elledge,et al.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. , 1999, Science.

[62]  J. Klijn,et al.  Survival in hereditary breast cancer associated with germline mutations of BRCA2. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  Ash A. Alizadeh,et al.  Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays , 1999, Nature Genetics.

[64]  T. Rebbeck.  Inherited genetic predisposition in breast cancer , 1999, Cancer.

[65]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[66]  B. Ponder,et al.  A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk 1 , 2000 .

[67]  Ash A. Alizadeh,et al.  Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.

[68]  D. Easton.  How many more breast cancer predisposition genes are there? , 1999, Breast Cancer Research.

[69]  C. Wang,et al.  Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. , 1999, Science.

[70]  Heinz Ruffner,et al.  BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site , 1999, Molecular and Cellular Biology.

[71]  A. Ashworth,et al.  Interaction between the Product of the Breast Cancer Susceptibility Gene BRCA2 and DSS1, a Protein Functionally Conserved from Yeast to Mammals , 1999, Molecular and Cellular Biology.

[72]  S. Seal,et al.  Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.

[73]  F. Christians,et al.  Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1 , 1999, Cell.

[74]  M. Erdos,et al.  BRCA1 inhibition of estrogen receptor signaling in transfected cells. , 1999, Science.

[75]  Thomas Ried,et al.  Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation , 1999, Nature Genetics.

[76]  M B Daly,et al.  Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. , 1999, American journal of human genetics.

[77]  H. Moch,et al.  High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. , 1999, The American journal of pathology.

[78]  Chun-Fang Xu,et al.  Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics , 1999, Oncogene.

[79]  Patrick E Carroll,et al.  Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression , 1999, Oncogene.

[80]  X. Wang,et al.  Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. , 1999, Molecular cell.

[81]  M. Bissell,et al.  Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. , 1999, Developmental biology.

[82]  I. Irminger-Finger,et al.  The Functions of Breast Cancer Susceptibility Gene 1 (BRCA1) Product and Its Associated Proteins , 1999, Biological chemistry.

[83]  H. Dietz,et al.  Nonsense-mediated mRNA decay in health and disease. , 1999, Human molecular genetics.

[84]  M. Bittner,et al.  Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.

[85]  F. Couch,et al.  Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. , 1998, Molecular cell.

[86]  B. Koller,et al.  BRCA1 required for transcription-coupled repair of oxidative DNA damage. , 1998, Science.

[87]  M. Stratton,et al.  Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.

[88]  J. Minna,et al.  Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. , 1998, Cancer research.

[89]  M. Fernö,et al.  Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes , 1998, Cancer.

[90]  D J Schaid,et al.  Increased Risk for Cancer in Patients with the Peutz-Jeghers Syndrome , 1998, Annals of Internal Medicine.

[91]  R. Peto,et al.  Variation in use of adjuvant tamoxifen , 1998, The Lancet.

[92]  T. Powles,et al.  Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers , 1998, The Lancet.

[93]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[94]  B. Trask,et al.  Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. , 1998, Human molecular genetics.

[95]  J. Klijn,et al.  Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 , 1998, The Lancet.

[96]  A. Ashworth,et al.  Nuclear location and cell cycle regulation of the BRCA2 protein. , 1997, Cancer research.

[97]  M. Lai,et al.  A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells. , 1997, Cancer research.

[98]  M N Pollak,et al.  Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women , 1997, Cancer.

[99]  D E Goldgar,et al.  Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. , 1997, American journal of human genetics.

[100]  M. Stratton.  Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.

[101]  F. Couch,et al.  BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. , 1997, The New England journal of medicine.

[102]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[103]  M. Hung,et al.  Changes in BRCA2 expression during progression of the cell cycle. , 1997, Biochemical and biophysical research communications.

[104]  M. King,et al.  Population genetics of BRCA1 and BRCA2. , 1997, American journal of human genetics.

[105]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[106]  G. Eichele,et al.  Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.

[107]  H. Gardner,et al.  Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. , 1997, Developmental biology.

[108]  J Isola,et al.  Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. , 1997, Cancer research.

[109]  Å. Borg,et al.  Tumour biological features of BRCA1-induced breast and ovarian cancer. , 1997, European journal of cancer.

[110]  P. Schlag,et al.  Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families , 1997, Oncogene.

[111]  Yonghong Xiao,et al.  Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.

[112]  J. Norton,et al.  Advances in molecular genetics. , 1997, American journal of surgery.

[113]  G. Casey.  The BRCA1 and BRCA2 breast cancer genes. , 1997, Current opinion in oncology.

[114]  T. Rebbeck,et al.  Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer. , 1997, Genetic testing.

[115]  S. Seal,et al.  Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene , 1997, Nature Genetics.

[116]  A. Ashworth,et al.  The BRC repeats are conserved in mammalian BRCA2 proteins. , 1997, Human molecular genetics.

[117]  M. Stratton,et al.  Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. , 1997, British Journal of Cancer.

[118]  M. Swift,et al.  Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. , 1996, Cancer genetics and cytogenetics.

[119]  L. Hood,et al.  Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. , 1996, Genome research.

[120]  N. Shao,et al.  Induction of apoptosis by the tumor suppressor protein BRCA1. , 1996, Oncogene.

[121]  H. Nguyen,et al.  Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[122]  J. Struewing,et al.  BRCA1 mutations in young women with breast cancer , 1996, The Lancet.

[123]  C. Osborne,et al.  Location of BRCA1 in Human Breast and Ovarian Cancer Cells , 1996, Science.

[124]  J. Rommens,et al.  The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.

[125]  B. Koller,et al.  Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities , 1996, Nature Genetics.

[126]  F. Couch,et al.  Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene , 1996, Human mutation.

[127]  M J Bissell,et al.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.

[128]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[129]  D. Bentley,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.

[130]  D. Clayton,et al.  Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation , 1995, Nature Genetics.

[131]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[132]  K. Kinzler,et al.  Serial Analysis of Gene Expression , 1995, Science.

[133]  D. Easton,et al.  Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.

[134]  M. Seller,et al.  Unusual case of Smith-Lemli-Opitz syndrome "type II". , 1995, American journal of medical genetics.

[135]  D. Easton,et al.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.

[136]  A. Whittemore,et al.  An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.

[137]  E. Taioli,et al.  Functional significance of different human CYP1A1 genotypes. , 1994, Carcinogenesis.

[138]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[139]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[140]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[141]  M. Rogers,et al.  Estrogen receptor expression of benign breast epithelium and its association with breast cancer. , 1994, Cancer research.

[142]  D. Easton.  Cancer Risks in A-T Heterozygotes. , 1994, International journal of radiation biology.

[143]  D. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.

[144]  Heekuck Oh,et al.  Neural Networks for Pattern Recognition , 1993, Adv. Comput..

[145]  M. Gerretsen,et al.  Br. J. Cancer , 1993 .

[146]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[147]  D Morrell,et al.  Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.

[148]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[149]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[150]  I. Jolliffe.  Principal Component Analysis , 2002, International Encyclopedia of Statistical Science.

[151]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[152]  W. Gardner,et al.  Carcinogenesis , 1961, The Yale Journal of Biology and Medicine.

[153]  Martin S. Fridson,et al.  Trends , 1948, Bankmagazin.